Clinical |
Subacute pontocerebellar dysfunction with or without other CNS symptoms such as cognitive dysfunction and myelopathy |
CNS symptoms responsive to corticosteroid therapy |
Absence of peripheral nervous system disease |
Lack of alternative explanation for clinical presentation |
Radiological |
MRI with homogeneous, gadolinium-enhancing nodules without ring enhancement or mass effect predominating in the pons or cerebellum measuring < 3 mm |
Marked improvement in gadolinium enhancement after corticosteroid treatment |
Homogeneous T2 signal abnormality where degree of T2 does not significantly exceed the size or area of post gadolinium enhancement |
Spinal lesions with similar T2 and gadolinium-enhancing lesions as above |
Pathological |
Lymphocytic inflammation with perivascular predominance and parenchymal diffuse infiltration |
T cells predominating infiltration with variable macrophage components |
Absence of myelin loss or focal secondary myelin loss |
Lack of alternative explanation for pathological presentation |
Definite CLIPPERS: patient fulfilling all clinical, radiological, and pathological criteria |
Probable CLIPPERS: patient fulfilling all clinical and radiological criteria without available pathology |
Differential diagnoses, including CNS lymphoma, lymphomatoid granulomatosis, glioma, primary CNS vasculitis, paraneoplastic syndrome, neurosarcoidosis, demyelinating disease, acute disseminated encephalomyelitis (ADEM), neuromyelitis optica (NMO) neuro-Behcet’s disease, Sjögren’s syndrome, tuberculosis, Whipple’s disease, and histiocytosis, should be excluded |